ý

Home
Section for epidemiology and medical statistics
DRONE

DRONE - Drug Repurposing fOr Neurological disEases

The project aims to develop new and effective treatments for the neurological diseases Parkinson's disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).

DRONE logo
Photo:
https://www.facebook.com/z.rmnwsk

Main content

The researchers will analyze data from the Norwegian health registries, including the Prescription Register and Patient Register, using an innovative drug repurposing approach based on the history of prescriptions for the entire Norwegian population during last 16 years. The newly developed methodology will help identify drug candidates for new treatment for the diseases.These candidates will be then validated in experimental studies (both in vitro and in vivo) in collaboration with the excellent researchers at Harvard University in Boston, USA

Apart from securing its own funding via and (The Research Council of Norway), DRONE is also part of the initiative on the treatment of neurological disease,(Norway's first research center for clinical treatment in neurology) at Haukeland University Hospital / UiB.

News

  1. Professorwill be awarded honorary doctorateat a ceremony to be held in the University Aula on May 24th🎉 His collaboration with the University of Bergen began many years ago when Ascherio was introduced to Professor Trond Riise, and the two began exploring the causes of MS. Connection to Bergen has strengthened over time, largely thanks to and
  2. (Norwegian newspaper) has interviewed Julia Romanowska:"Study: Linking Parkinson's to drug use."
  3. New article with Julia Romanowska first author i Neurology:
  4. NEW article fromPhD CandidateAkash Kapali:
  5. Master's student passed his master's exam on June 14! DRONE congratulates Muhammad!
  6. NEW article fromPhD CandidateJulia Axiina Tuominen:
  7. DRONE group had a one-day long seminar at Augustin Hotel 17th November 2022
  8. DRONE welcome ,MSc Global Health student at The University of Bergen!
  9. Asieh Abolpour Mofrad will defend her dissertation on 15.11.2021 for the PhD degree at the University of Bergen with the dissertation"Clique-Based Neural Associative Memories".
  10. September 16th 2021 14:00-14:45: Trial lecture - PhD Asieh Abolpour Mofrad
  11. August 2021: Asieh Abolpour Mofrad has started in DRONE - welcome!
  12. April 2021:Hopefully a DRONE seminar will be arranged at 26-27May!
  13. March 2021: We are looking forward to Asieh Abolpour Mofrad starting with us in August as a postdoctoral fellow!
  14. Sept.2020: Welcome to two new PhD students, Julia Tuominen and Akash Kapali!
  15. Sept. 2020: We have received extra funding from ALS patients’ association ()! This will help us dedicate a full PhD-position to research on this disease.

Presentations

  • Julia Romanowska presented"" at TRACE - opening seminar 19thFebruary 2024.

  • Trond Riise presented at a conference in Italy 16th November 2023: "Use of Artificial Intelligence on registry data to screen for repurposing drugs in neurodegenerative diseases" Conference webpage (italian):

  • Julia Romanowska presented "" at "The 29thNorwegian Epidemiological Association (NOFE) conference in Trondheim (15thto 16thNovember 2023)"

  • Akash Kapalipresented MoBa findings at - world’s largest research meeting in multiple sclerosis held 11-13 October at Allianz MiCo in Milan. "Dietary vitamin D and the risk of multiple sclerosis in the Norwegian Mother and Child cohort"(oral presentation)
    Multiple Sclerosis Journal. 2023;29(3_suppl):4-136. doi:

  • Neuro-SysMed Annual Symposium 2023, September 25-26, 2023 Solstrand, Norway:
    Julia Axiina Tuominen presented with the title: «Medication use after diagnosis and Parkinson’s disease survival: A target trial approach”. See
    Akash Kapali presented with the title: “Dietary vitamin D and the risk of multiple sclerosis in the Norwegian Mother, Father and Child cohort” See.

  • Muhammad gave two presentations about his master project at the German Center for Neurodegenerative Diseases () and at the FEST Seminar.

  • Trond was presenting DRONE at Datathon () and will be presenting at /ai/157424/uib-ai-4-examples-medical-ai

  • Akash was attending ECTRIMS (26-28 Oct.,)

  • Muhammad and Jannicke were attending NOFE ()

  • Julia T.:( 02:48 PM - 03:00 PM PDT Abstract 010 - Selective ß2-Adrenoreceptor Agonists and Long-Term Parkinson’s Disease Risk Julia Axiina Tuominen, MPsych)
  • Julia T.:Poster:"Definition and Incidence of Parkinson’s Disease Based onNationwide Prescription- and Diagnostic Data" at(3-7. October 2021)
  • Trond: Abstract "A reverse translational research project for identifying new treatments for Parkinson’s disease: The Italian/Norwegian drug-screening project" at (24. Sept 2021)
  • Julia R.: R-Medicine () (Thursday, August 26th 2021)
  • Julia R.: Bioinformatics in Bergen (18-19. Aug. 2021)
  • Julia R.: CEDAS Diving into registry data() (1-2. June2021)

Collaborators

Publications

Kapali A, Daltveit AK, Myhr KM, Bjornevik K, Baldin E, Pugliatti M, Riise T, Cortese M.J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):8-13.

Romanowska J, Bjornevik K, Cortese M, Tuominen JA, Solheim M, Abolpour Mofrad A, Igland J, Scherzer CR, Riise T.Neurology. 2023 Nov 21;101(21):e2068-e2077.

Tuominen JA, Bjørnevik K,Romanowska J, Solheim MH, Grydeland TB, Cortese M, Scherzer CR, Riise T, Igland J.Parkinsonism Relat Disord. 2023 May;110:105389.

Eid K, Torkildsen Ø, Aarseth J, Celius EG, Cortese M, Holmøy T,Kapali A, Myhr KM, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH.J Neurol. 2022 Nov;269(11):5901-5909.